{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-046001","form_type":"8-K","ticker":"BCLI","cik":"0001137883","company_name":"BRAINSTORM CELL THERAPEUTICS INC.","filed_at":"2024-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.424598+00:00","generated_at":"2026-06-03T23:49:29.627275+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Brainstorm Cell regains Nasdaq minimum market value compliance","bullets":["Received Nasdaq notification on April 10, 2024 that it regained compliance with Listing Rule 5550(b)(2).","Market value of listed securities was >= $35M for 11 consecutive business days (Mar 22 – Apr 9, 2024).","Previous deficiency notice received November 6, 2023; matter now closed.","Continued listing on Nasdaq Capital Market is no longer in jeopardy.","Press release issued April 11, 2024 confirms compliance reinstatement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-046001","json":"https://secwatch.observer/filing/0001104659-24-046001.json","markdown":"https://secwatch.observer/filing/0001104659-24-046001.md","text":"https://secwatch.observer/filing/0001104659-24-046001.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924046001/0001104659-24-046001-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924046001/tm2411567d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T23:49:29.627275+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}